Wolverine Asset Management’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Wolverine Asset Management’s Portfolio IBER.U Stock Details IBER.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,500	Closed	-$94K	–	2551
2022 Q3	$94K	Sell	9,500 -6,261	-40%	-$62K	﹤0.01%	1448
2022 Q2	$154K	Buy	15,761 +1,800	+13%	+$17.7K	﹤0.01%	1269
2022 Q1	$137K	Buy	13,961 +9,220	+194%	+$91.8K	﹤0.01%	1235
2021 Q4	$47K	Sell	4,741 -4,412	-48%	-$44K	﹤0.01%	1529
2021 Q3	$91K	Buy	9,153 +1,041	+13%	+$10.4K	﹤0.01%	1315
2021 Q2	$81K	Sell	8,112 -1,888	-19%	-$18.9K	﹤0.01%	1540
2021 Q1	$98K	Buy	+10,000	New	+$100K	﹤0.01%	1451

Other funds holding IBER.U

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

TAM

Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wolverine Asset Management's IBER.U Position: Q4 2022 in Review

Wolverine Asset Management sold out of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) in Q4 2022, closing a stake of 9,500 shares — an estimated $94K sold.

Wolverine Asset Management first reported a position in IBER.U in Q1 2021 and held it in 7 quarters. The position peaked at $154K in Q2 2022. 10 funds tracked by Wall St. Rank hold IBER.U as of Q4 2022.

Wolverine Asset Management reported no remaining Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position as of Q4 2022 after selling out during the quarter.
Wolverine Asset Management sold 9,500 Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant shares in Q4 2022, an estimated $94K.
Wolverine Asset Management first reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in Q1 2021 and held it in 7 quarters.
Wolverine Asset Management's Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position peaked at $154K in Q2 2022.
10 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.